Company: FENC
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001558370-25-005563
Chunk: 29

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 29
---
                     - | ​ |         -982,763 | ​ |     1,960,657 |
| 2024        | ​ | Non-PEO NEOs | ​ |    1,122,451 | ​ |       602,826 | ​ |                662,476 | ​ |                  - | ​ |               -63,392 | ​ |         -138,710 | ​ |       979,998 |
| 2023        | ​ | Prior PEO    | ​ |    2,497,849 |   |     1,655,873 | ​ |              2,283,329 | ​ |                  - | ​ |              -618,750 | ​ |        2,019,956 | ​ |     4,526,511 |
| 2023        |   | Non-PEO NEOs | ​ |    1,234,679 | ​ |       856,335 | ​ |              1,244,623 | ​ |                  - | ​ |               -19,094 | ​ |          432,411 | ​ |     2,036,284 |
| 2022        | ​ | Prior PEO    | ​ |      614,161 | ​ |             - | ​ |                      - | ​ |                  - | ​ |              -850,186 | ​ |        1,805,489 | ​ |     1,569,464 |
| 2022        | ​ | Non-PEO NEOs | ​ |      428,919 | ​ |             - | ​ |                      - | ​ |                  - | ​ |              -221,690 | ​ |          989,866 | ​ |     1,197,095 |

| (a) | The grant date fair value of equity-based awards, as reported in the Summary Compensation Table. |

| (b) | The year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year. |

| (c) | For awards granted and vested in the current fiscal year, the amount equals the fair value at the vesting date. |

| (d) | The amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year. |

|